MRD / Regn No. : 20160003029 Date : 22/06/2026
Patient Name : Mangayarkarasi Bhaskar Age & Gender : 62 Yrs. / Female
Contact No. : 9840062330 UHID :
Ht / Wt / BMI : 151 / 63 / 27.63 BP S / BP D : 95 / 71
Allergies : NKA Referred By :
   
Problem List : HYPOTHYROIDISM, UNSPECIFIED (01/Jan/2001) | TYPE 2 DM (01/Jan/2004) | DYSLIPIDEMIA (23/Sep/2004) | INTOLERANCE TO GLP1RA (10/Oct/2025) |
Subjective : NO NEW COMPLAINTS,STRESS AND URGE INCONTINENCE,TOLERATING SEMAGLUTIDE 0.5 MG
Objective : NONE
Analysis : TYPE 2 DM IMPROVED CONTROL,LOSS OF PROTECTIIVE SENSATION
Plan : SEE ME IN 2 MONTHS WITH TESTING,DECERASE LT4 75 MCG  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 112 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.8 % | POST PRANDIAL GLUCOSE (2HPP): 183 mg/dL | FREE T3: 2.9 ng/dL | FREE T4 : 1.7 ng/dL | TSH : 0.06 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 CHOLECALCIFEROL 1000 IU
UPRISE D3 1000 IU
Medicine For VITAMIN D 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
TAKE AT BEDTIME
2 CREAM ESTRIOL CREAM
EVALON 		PV TWICE A MONTH AS DIRECTED
 TILL NEXT VISIT
3 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES 		SQ 24-0-18 UNITS BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
4 ROSUVASTATIN 10 MG
CRESTOR 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY
5 TELMISARTAN H 80 MG
TELMA H 80 MG
Medicine For HYPERTENSION KIDNEY CONTROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE INCREASE IN POTASSIUM
6 INJECTION OZEMPIC
SEMAGLUTIDE 0.5 MG
Medicine For DIABETES 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
 TILL NEXT VISIT
MAY CAUSE NAUSEA OR VOMITING
7 POWDER MEAL REPLACEMENT
ENSURE DIABETES CARE
Medicine For MEAL REPLACEMENT 		PO
8 TABLET THYROXINE 75 MCG
THYRONORM 75 MCG
Medicine For HYPOTHYROIDISM 		PO 1-0-0 EMPTY STOMACH
 TILL NEXT VISIT
MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE
       
Refill : 0 / Substitution:    
Education : DURING TRANSITION OF DOSE THERE MAY BE WORSENING OF NAUSEA VOMITING OR DIARRHEA AND FATIGUE THIS IS USUALLY TRANSIENT
Next Visit : 21/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C FREE T4 TSH
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: